🧸 New Pneumococcal Vaccine Study for Infants (2 Months Old)

Leavitt Clinical Research is enrolling infants 2 months of age for a new study evaluating the safety and effectiveness of a potential vaccine designed to help prevent infections caused by Streptococcus pneumoniae — including pneumonia and meningitis.

Participants will:

-Receive a pneumococcal vaccine along with all other routine immunizations for their first year

-Receive all study-related care and vaccines at no cost

-May be compensated up to $1,400 for their time and participation